targets

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

Source Node:
Time Stamp: February 7, 2024 10:46 AM - Modified On: February 7, 2024 - Published By:
Source Cluster:
Republished By Plato

Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio industry welcomed the parliament’s passage of a bill that adds regenerative medicine organizations to the list of those considered for human cell management business licenses. The National Assembly passed the “Amendment to the Act on Safety and Support for Advanced Regenerative Medicine and Advanced Biopharmaceuticals” in a plenary session paving the way for certain next generation NK Cell Therapy companies to recognized as a licensed

D8X Re-Engineers DeFi Derivatives With Launch on Polygon zkEVM

Source Node:
Time Stamp: February 6, 2024 2:03 PM - Modified On: February 6, 2024 - Published By:
Source Cluster:
Republished By Plato

Supported by Polygon Ventures, D8X targets institutional users with next-gen DEX engine, innovative features, novel white-label approach [Zug, Switzerland - Feb. 6, 2024] - D8X, an institutional-grade decentralized exchange (DEX) for derivatives, has launched on Polygon zkEVM, establishing a new benchmark for decentralized finance. With support from Polygon Ventures and other notable partners, D8X reconceives on-chain derivatives, starting from fundamental financial engineering and extending to its novel white-label business-to-business model–a first for Polygon zkEVM. Until now, users seeking the trading experience offered by D8X have had to resort to Centralized

Blueberry Protocol Launches High-Leverage DeFi Hub Optimized For Liquidity Access and Risk Control

Source Node:
Time Stamp: January 23, 2024 12:25 PM - Modified On: January 23, 2024 - Published By:
Source Cluster:
Republished By Plato

[PANAMA CITY, PANAMA] January 23, 2024 – Blueberry Protocol today announces the launch of its decentralized prime brokerage terminal, delivering industry-leading Loan-to-Value (LTV) ratios of up to 20x for optimized on-chain trading and yield strategies. Blueberry is the first protocol to enable decentralized access to generalized leverage models with leverage on Ethereum and offers an increasing value opportunity with more sophisticated security management and higher leverage than traditional prime brokerage. By merging innovative and transparent risk management instruments with an advanced leverage architecture, Blueberry aims to broaden accessibility, increase efficiency,

Livento Group, Inc. Announces Second Quarter Results with Revenue Growth of Over 90%, Including Significant Achievements and Updates

Source Node:
Time Stamp: August 17, 2023 3:05 PM - Modified On: August 17, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK, NY / August 14, 2023 / NuGene International, Inc./Livento Group, Inc. (OTC Pink:NUGN), a dynamic leader specializing in the acquisition and development of companies with disruptive business models in film, content, and technology sectors, is pleased to announce revenue growth of 91.65% for the second quarter of 2023, compared to the same period in 2022. Financial Highlights: Revenue Growth:The second quarter ending June 30, 2023, saw revenues of $431,184, up from $224,986 in 2022. For the six-month period ending June 30, 2023, revenues grew from $680,202 to $922,651, a growth of